Scutellaria baicalensis Ameliorates Acute Lung Injury by Suppressing Inflammation In Vitro and In Vivo

Am J Chin Med. 2017;45(1):137-157. doi: 10.1142/S0192415X17500100. Epub 2017 Jan 13.

Abstract

Scutellaria baicalensis has been widely used as both a dietary ingredient and traditional herbal medicine in Taiwan to treat inflammation, cancer, and bacterial and viral infections of the respiratory tract and gastrointestinal tract. This paper aims to investigate the in vitro and in vivo anti-inflammatory effects of S. baicalensis. In HPLC analysis, the fingerprint chromatogram of the water extract of S. baicalensis (WSB) was established. The anti-inflammatory effects of WSB were inverstigated using lipopolysaccharide (LPS)-stimulated mouse macrophage (RAW264.7) in vitro and LPS-induced lung injury in vivo. WSB attenuated the production of LPS-induced nitric oxide (NO), tumor necrosis factor-alpha (TNF-[Formula: see text], interleukin-[Formula: see text] (IL-1[Formula: see text], and IL-6 in vitro and in vivo. Pretreatment with WSB markedly reduced the LPS-induced histological alterations in lung tissues. Furthermore, WSB significantly reduced the number of total cells and the protein concentration levels in the BALF. WSB blocked protein expression of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), phosphorylation of I[Formula: see text]B-[Formula: see text] protein and MAPKs in LPS-stimulated RAW 264.7 cells and LPS-induce lung injury was also blocked. This study suggests that WSB possesses anti-inflammatory effects in vitro and in vivo, and the results suggested that WSB may be a potential therapeutic candidate for the treatment of inflammatory diseases.

Keywords: Acute Lung Injury; Lipopolysaccharide; MAPK; Nitric Oxide; Scutellaria baicalensis.

MeSH terms

  • Acute Lung Injury / immunology*
  • Acute Lung Injury / metabolism
  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Chromatography, High Pressure Liquid
  • Cyclooxygenase 2 / drug effects
  • Cyclooxygenase 2 / metabolism
  • In Vitro Techniques
  • Inflammation*
  • Interleukin-1beta / drug effects
  • Interleukin-1beta / immunology
  • Interleukin-6 / immunology
  • Lipopolysaccharides / pharmacology
  • Lung / drug effects*
  • Lung / immunology
  • Lung / metabolism
  • Macrophages / drug effects*
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mitogen-Activated Protein Kinases / drug effects
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-KappaB Inhibitor alpha / drug effects
  • NF-KappaB Inhibitor alpha / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / drug effects
  • Nitric Oxide Synthase Type II / metabolism
  • Phosphorylation / drug effects
  • Plant Extracts / pharmacology*
  • Scutellaria baicalensis
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Inflammatory Agents
  • IL1B protein, mouse
  • Interleukin-1beta
  • Interleukin-6
  • Lipopolysaccharides
  • Plant Extracts
  • Scutellaria baicalensis extract
  • Tumor Necrosis Factor-alpha
  • interleukin-6, mouse
  • NF-KappaB Inhibitor alpha
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Mitogen-Activated Protein Kinases